Enlivex Therapeutics

ENLV

NASDAQHealth Care

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$-15.89M

EBITDA$-15.34M

EBIT$-15.89M

Pre-tax Income$1.62B

Net Income$-15.01M

Net Cash$15.8M

Cash Equivalent$24.34M

Total Debt$0

Net Debt$-15.8M

Book Value$26.4M

Net Cash Per Share0.07

Book Value Per Share1.32

Return on Equity (ROE)-63.65%

Return on Assets (ROA)-54.23%

Return on Invested Capital (ROI)-63.65%

Net Profit Marginundefined

Current Ratio6.84

Quick Ratio6.27

Long-Term Debt / Equitynull